Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur J L Cooper

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Neurochemistry International|March 16, 2004
The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicantsArthur J L Cooper
Neurochemical Research|May 24, 2012
The role of glutamine synthetase and glutamate dehydrogenase in cerebral ammonia homeostasisArthur J L Cooper
Frontiers in Endocrinology|December 5, 2013
Quantitative analysis of neurotransmitter pathways under steady state conditions - a perspectiveArthur J L Cooper
Metabolic Brain Disease|October 16, 2012
Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetaseArthur J L Cooper
Neurochemistry International|November 27, 2010
13N as a tracer for studying glutamate metabolismArthur J L Cooper
Current Drug Targets. CNS and Neurological Disorders|April 14, 2004
Transglutaminases - possible drug targets in human diseasesVittorio Gentile, Arthur J L Cooper
Neurochemical Research|August 13, 2016
Reciprocal Control of Thyroid Binding and the Pipecolate Pathway in the BrainAndré Hallen, Arthur J L Cooper
Metabolic Brain Disease|November 16, 2013
α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycleArthur J L Cooper, Tomiko Kuhara
Genes|April 25, 2020
A Novel Cosegregating <i>DCTN1</i> Splice Site Variant in a Family with Bipolar Disorder May Hold the Key to Understanding the EtiologyAndré Hallen, Arthur J L Cooper
Critical Care Medicine|June 28, 2011
Encephalopathy in acute liver failure resulting from acetaminophen intoxication: new observations with potential therapySaul W Brusilow, Arthur J L Cooper
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Neurochemistry International|March 16, 2004
The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicantsArthur J L Cooper
Neurochemical Research|May 24, 2012
The role of glutamine synthetase and glutamate dehydrogenase in cerebral ammonia homeostasisArthur J L Cooper
Frontiers in Endocrinology|December 5, 2013
Quantitative analysis of neurotransmitter pathways under steady state conditions - a perspectiveArthur J L Cooper
Metabolic Brain Disease|October 16, 2012
Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetaseArthur J L Cooper
Neurochemistry International|November 27, 2010
13N as a tracer for studying glutamate metabolismArthur J L Cooper
Current Drug Targets. CNS and Neurological Disorders|April 14, 2004
Transglutaminases - possible drug targets in human diseasesVittorio Gentile, Arthur J L Cooper
Neurochemical Research|August 13, 2016
Reciprocal Control of Thyroid Binding and the Pipecolate Pathway in the BrainAndré Hallen, Arthur J L Cooper
Metabolic Brain Disease|November 16, 2013
α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycleArthur J L Cooper, Tomiko Kuhara
Genes|April 25, 2020
A Novel Cosegregating <i>DCTN1</i> Splice Site Variant in a Family with Bipolar Disorder May Hold the Key to Understanding the EtiologyAndré Hallen, Arthur J L Cooper
Critical Care Medicine|June 28, 2011
Encephalopathy in acute liver failure resulting from acetaminophen intoxication: new observations with potential therapySaul W Brusilow, Arthur J L Cooper
Pageof 11